Companies Were Big on CBD. Not Anymore.

Companies Were Big on CBD. Not Anymore.

The New York Times - Business:

A lack of federal regulation and a mishmash of state laws have made selling products featuring the cannabis-derived ingredient not worth the trouble.

This post first appeared in The New York Times - Business. Read the original article.